After ASHG, Analysts Say Future is 'Murky' for Expression Arrays, 'Secure' for Genotyping Chips | GenomeWeb

An earlier version of this article attributed a statement to NCGR President Greg May that was actually made by HudsonAlpha investigator Shawn Levy. The story has now been corrected.

By Justin Petrone

The future is uncertain for gene-expression microarrays as applications based on high-throughput sequencers continue to come down in price. At the same time, the market for genotyping chips is less likely to face competition from sequencing, according to two analysts familiar with the industry.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.